Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 224,413,788 papers from all fields of science
Search
Sign In
Create Free Account
0.6 ML Fondaparinux sodium 12.5 MG/ML Prefilled Syringe [Arixtra]
Known as:
FONDAPARINUX SODIUM 7.5 mg in 0.6 mL SUBCUTANEOUS INJECTION, SOLUTION [ARIXTRA]
, 0.6 ML Arixtra 12.5 MG/ML Prefilled Syringe
, Arixtra 7.5 MG in 0.6 ML Prefilled Syringe
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
Arixtra
Fondaparinux sodium
Prefilled Syringe
Sodium Chloride
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Advancing MSn spatial resolution and documentation for glycosaminoglycans by sulfate-isotope exchange
Qing Guo
,
V. Reinhold
Analytical and Bioanalytical Chemistry
2019
Corpus ID: 172136304
Glycosaminoglycans (GAGs) are carbohydrate polyionic polymers that participate in a host of critically important biological…
Expand
2012
2012
A closer look at the nitrogen next door: 1H-15N NMR methods for glycosaminoglycan structural characterization.
Derek J. Langeslay
,
S. Béni
,
C. Larive
Journal of magnetic resonance (San Diego, Calif…
2012
Corpus ID: 30643914
Review
2012
Review
2012
Spotlight on Fondaparinux Sodium in Acute Coronary Syndromes
S. Blick
,
Jennifer S. Orman
,
A. Wagstaff
,
L. Scott
BioDrugs
2012
Corpus ID: 19447499
Fondaparinux sodium (Arixtra®) is a synthetic, sulfated pentasaccharide, selective factor Xa inhibitor that is indicated in…
Expand
2010
2010
[Use of fondaparinux during hemodialysis in heparin-induced thrombocytopenia. About a new observation].
R. Montagnac
,
Saïd Brahimi
,
Pascale Janian
,
Jean-Pierre Melin
,
J. Bertocchio
,
A. Wynckel
Néphrologie & Thérapeutique
2010
Corpus ID: 196395990
2007
2007
National Pharmacovigilance Enquiry about Arixtra® (Fondaparinux)
A. L. Louët
,
D. Smadja
,
C. Beller
2007
Corpus ID: 71906000
2006
2006
Les nouveaux antithrombotiques : une thérapeutique en mutation, des perspectives d'avenir
J. Girardel
,
C. Samama
2006
Corpus ID: 58113047
2004
2004
Le pentasaccharide (fondaparinux sodium, Arixtra ® ) : avantage à la synthèse ?
R. Cariou
2004
Corpus ID: 70611361
Auteur(s) :, Roger Cariou* Departement therapeutique thrombose, Sanofi Synthelabo Recherche, 91385 Chilly Mazarin cedex, France…
Expand
2004
2004
Initial Outpatient Treatment of Venous Thromboembolism with Fondaparinux (Arixtra®): The Matisse Trials.
H. Büller
2004
Corpus ID: 78342624
Background: The MATISSE trials showed that a single dose regimen of fondaparinux, a synthetic selective factor Xa inhibitor, was…
Expand
2004
2004
Efficacy and Safety of Fondaparinux (ARIXTRA®) in the Initial Treatment of Venous Thromboembolism in Obese Patients.
H. Büller
2004
Corpus ID: 78922293
Background: The MATISSE trials demonstrated that once-daily subcutaneous fondaparinux, a synthetic selective factor Xa inhibitor…
Expand
2003
2003
Cost-effectiveness of fondaparinux (Arixtra®) compared with enoxaparin as prophylaxis against venous thromboembolism following major orthopedic surgery
L. Annemans
,
K. Groot
2003
Corpus ID: 75672656
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE